L

Lytix Biopharma AS
OSE:LYTIX

Watchlist Manager
Lytix Biopharma AS
OSE:LYTIX
Watchlist
Price: 6.68 NOK -1.76% Market Closed
Market Cap: 331.4m NOK
Have any thoughts about
Lytix Biopharma AS?
Write Note

Lytix Biopharma AS
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Lytix Biopharma AS
Net Change in Cash Peer Comparison

Comparables:
HBC
B
BGBIO
AZT
N
NYKD
T
TRMED

Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
L
Lytix Biopharma AS
OSE:LYTIX
Net Change in Cash
-kr67.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hofseth Biocare ASA
OSE:HBC
Net Change in Cash
kr8.6m
CAGR 3-Years
-45%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
B
Bergenbio ASA
OSE:BGBIO
Net Change in Cash
-kr25.9m
CAGR 3-Years
53%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Arcticzymes Technologies ASA
OSE:AZT
Net Change in Cash
-kr4.2m
CAGR 3-Years
N/A
CAGR 5-Years
21%
CAGR 10-Years
N/A
N
Nykode Therapeutics ASA
OSE:NYKD
Net Change in Cash
-$37m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Thor Medical ASA
OSE:TRMED
Net Change in Cash
-kr20.6m
CAGR 3-Years
N/A
CAGR 5-Years
30%
CAGR 10-Years
-7%

See Also

What is Lytix Biopharma AS's Net Change in Cash?
Net Change in Cash
-67.2m NOK

Based on the financial report for Dec 31, 2023, Lytix Biopharma AS's Net Change in Cash amounts to -67.2m NOK.

What is Lytix Biopharma AS's Net Change in Cash growth rate?
Net Change in Cash CAGR 1Y
35%

Over the last year, the Net Change in Cash growth was 35%.

Back to Top